ES8706595A1 - Un procedimiento para la preparacion de derivados del glicerol - Google Patents

Un procedimiento para la preparacion de derivados del glicerol

Info

Publication number
ES8706595A1
ES8706595A1 ES556110A ES556110A ES8706595A1 ES 8706595 A1 ES8706595 A1 ES 8706595A1 ES 556110 A ES556110 A ES 556110A ES 556110 A ES556110 A ES 556110A ES 8706595 A1 ES8706595 A1 ES 8706595A1
Authority
ES
Spain
Prior art keywords
formula
group
inhibitors
residues
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556110A
Other languages
English (en)
Other versions
ES556110A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES556110A0 publication Critical patent/ES556110A0/es
Publication of ES8706595A1 publication Critical patent/ES8706595A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DEL GLICEROL. CONSISTE EN HAER REACCIONAR A UN COMPUESTO DE FORMULA (II) CON UNA AMINA DE FORMULA (NR), EN ACETONITRILO O BENCENO Y ENTRE 0 Y 80GC, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS HIDRATOS. SIENDO: A ELEVADO A 1 Y A ELEVADO A 2, O O NQ ELEVADO A 2; A ELEVADO A -, ANION DE ACIDO FUERTE; R ELEVADO A 1 Y R ELEVADO A 4, U; R ELEVADO A 2 Y R ELEVADO A 5, V [R ELEVADO A 3 Y R ELEVADO A 6, W] Q ELEVADO A 1, Q ELEVADO A 2 Y Q ELEVADO A 3, H, ALQUILO DE C 1 A 4 Y OTROS; R, Y ELEVADO A 3, Y ELEVADO A 4 O Y ELEVADO A 6; U, OY ELEVADO A 1 O -X ELEVADO A 1-CO-(A ELEVADO A 1)N-Z ELEVADO A 1; V ELEVADO A 1, OY ELEVADO A 2 O -X ELEVADO A2-CO-(A ELEVADO A 2)P-Z ELEVADO A 2; W, -X ELEVADO A 3-T-(C2-6-ALQUILENO)-N ELEVADO A + RA ELEVADO A -; T, METILENO; X ELEVADO A 1, X ELEVADO A 2 Y X ELEVADO A 3, O O NQ ELEVADO A 1; Y ELEVADO A 1, ALQUILO DE C 110 A 26; Y ELEVADO A 2, ALQUILO DE C 1 A 6; Y ELEVADO A 3, Y ELEVADO A 4, Y ELEVADO A 5, ALQUILO DE 1 A 6; Z ELEVADO A 1, ALQUILO DE C 9 A 25, ALQUILO; Y Z ELEVADO A 2, ALQUILO DE C 1 A 5. SE UTILIZAN COMO ANTITOMORALES. *FORMULA*
ES556110A 1985-06-18 1986-06-17 Un procedimiento para la preparacion de derivados del glicerol Expired ES8706595A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH256785 1985-06-18

Publications (2)

Publication Number Publication Date
ES556110A0 ES556110A0 (es) 1987-07-16
ES8706595A1 true ES8706595A1 (es) 1987-07-16

Family

ID=4236705

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556110A Expired ES8706595A1 (es) 1985-06-18 1986-06-17 Un procedimiento para la preparacion de derivados del glicerol

Country Status (16)

Country Link
US (2) US4863941A (es)
EP (1) EP0208932A3 (es)
JP (1) JPS61293954A (es)
KR (1) KR870000282A (es)
AR (1) AR242175A1 (es)
AU (1) AU596593B2 (es)
DK (1) DK281886A (es)
ES (1) ES8706595A1 (es)
FI (1) FI862560A (es)
HU (1) HU196350B (es)
IL (1) IL79120A0 (es)
MC (1) MC1757A1 (es)
NO (1) NO862403L (es)
NZ (1) NZ216546A (es)
PT (1) PT82772B (es)
ZA (1) ZA864486B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007099A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
US5185334A (en) * 1989-07-31 1993-02-09 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
WO1989007100A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
US5273985A (en) * 1988-07-04 1993-12-28 Eisai Co., Ltd. Glycerin derivative and its pharmacological use
FI97883C (fi) * 1988-07-04 1997-03-10 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen glyserolijohdannaisen valmistamiseksi
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.
JP2604268B2 (ja) * 1990-04-09 1997-04-30 富士写真フイルム株式会社 ペプチド誘導体両親媒性化合物、その中間体、ペプチド誘導体両親媒性化合物を用いたリポソームおよび薄膜
US5633274A (en) * 1993-02-18 1997-05-27 President And Fellows Of Harvard College Cancer treatments
US5512591A (en) * 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
US5556871A (en) * 1995-04-24 1996-09-17 President & Fellows Of Harvard College Method for treating epithelial precancerous lesions with topical inidazoles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790089A (fr) * 1971-10-14 1973-04-13 Ici Ltd Derives de l'imidazole
US4493832A (en) * 1981-07-03 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same
JPS5835194A (ja) * 1981-08-25 1983-03-01 Takeda Chem Ind Ltd カルバミン酸エステル類
JPH0240648B2 (ja) * 1981-08-25 1990-09-12 Takeda Chemical Industries Ltd Ketsushobankatsuseiinshokuseizai
JPS58154512A (ja) * 1982-03-09 1983-09-14 Takeda Chem Ind Ltd 血小板活性化因子抑制剤
DE3212387A1 (de) * 1982-04-02 1983-10-13 Bayer Ag, 5090 Leverkusen Glycerinphosphatide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPS58192825A (ja) * 1982-05-06 1983-11-10 Takeda Chem Ind Ltd グリセロール誘導体
EP0094586A3 (en) * 1982-05-13 1984-06-06 Ono Pharmaceutical Co., Ltd. Glycerol derivatives, process for preparing same and pharmaceutical composition containing same
JPS5931738A (ja) * 1982-08-17 1984-02-20 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
JPS5988447A (ja) * 1982-11-11 1984-05-22 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
JPS604196A (ja) * 1983-06-22 1985-01-10 Nippon Soda Co Ltd グリセリン誘導体
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JPS60100544A (ja) * 1983-11-08 1985-06-04 Ono Pharmaceut Co Ltd 新規なグリセリン誘導体，その製造方法及びその誘導体を含有する薬剤
JPS60104066A (ja) * 1983-11-10 1985-06-08 Ono Pharmaceut Co Ltd グリセリン誘導体
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
DE3586746T2 (de) * 1984-04-03 1993-03-04 Takeda Chemical Industries Ltd Lipidderivate, ihre produktion und verwendung.
JPH06419A (ja) * 1992-06-22 1994-01-11 Amada Co Ltd 工業用ロボットの制御装置
JPH08335194A (ja) * 1995-06-07 1996-12-17 Canon Inc 情報処理装置及び情報処理方法

Also Published As

Publication number Publication date
DK281886D0 (da) 1986-06-16
NO862403L (no) 1986-12-19
JPS61293954A (ja) 1986-12-24
KR870000282A (ko) 1987-02-17
NO862403D0 (no) 1986-06-17
NZ216546A (en) 1990-03-27
ZA864486B (en) 1987-02-25
FI862560A0 (fi) 1986-06-16
PT82772B (pt) 1989-01-17
ES556110A0 (es) 1987-07-16
US5057530A (en) 1991-10-15
HU196350B (en) 1988-11-28
EP0208932A3 (de) 1989-11-29
US4863941A (en) 1989-09-05
IL79120A0 (en) 1986-09-30
HUT43803A (en) 1987-12-28
PT82772A (en) 1986-07-01
FI862560A (fi) 1986-12-19
EP0208932A2 (de) 1987-01-21
MC1757A1 (fr) 1987-04-24
AR242175A1 (es) 1993-03-31
DK281886A (da) 1986-12-19
AU5890186A (en) 1986-12-24
AU596593B2 (en) 1990-05-10

Similar Documents

Publication Publication Date Title
ES8701138A1 (es) Un procedimiento para la preparacion de derivados de glicerina.
ES8706595A1 (es) Un procedimiento para la preparacion de derivados del glicerol
ES8705372A1 (es) Un procedimiento para la preparacion de derivados monoamidi-cos de etilendiamina
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
HUP0203117A2 (hu) Semleges kationos lipid nukleinsav és hatóanyag szállítására
MY108259A (en) Liquid detergent composition
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
AU7509481A (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
ES2027550A6 (es) Procedimiento para preparar derivados de glicerol.
AU7414691A (en) New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them
TW328957B (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
IE893956L (en) Novel compounds
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
AU586086B2 (en) 1,5-benzothiazepine derivatives, their preparation and compositions containing them
ES2001389A6 (es) Procedimiento para preparar derivados de o-toluidina
EP0098609A3 (en) Novel cephalosporin compounds
ES8702379A1 (es) Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas.
ES8801633A1 (es) Procedimiento para preparar nuevos derivados de 3-piridil-metilnaftilo
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
ZA849159B (en) N-(methoxyphenacyl)-amine derivatives
ES8308546A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES8704951A1 (es) Un procedimiento para la preparacion de nuevos derivados penem.
HUP0001058A2 (hu) 5-Hidroxi-metil-2-amino-tetralinok mint szív-érrendszerre ható szerek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények